Activation of EGFR signaling by TMEM16A is further demonstrated by Britschgi et al. showing that TMEM16A knockdown reduced EGFR phosphorylation and subsequently inhibited AKT, SRC, and ERK activation in breast cancer cell lines [42]. The gene discussed is ANO1; the disease is breast carcinoma.